Intellia Therapeutics stock plunges after phase 2 results from NTLA-2002 study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. SPCX
7. AVGO
8. RMAX
9. HD
10. BJ

Go back to Intellia Therapeutics stock plunges after phase 2 results from NTLA-2002 study
(NASDAQ: NTLA) Delayed: 12.84 +0.40 (3.22%)
Previous Close $12.44    52 Week High $30.40 
Open $12.65    52 Week Low $11.86 
Day High $13.13    P/E N/A 
Day Low $12.65    EPS $0.00 
Volume 3,347,484